Medical News

RSS

Pernix first quarter net revenues increase 14% to $10.1 million

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company primarily focused on the pediatric market, today announced financial results for the first quarter of 2011.

17 May 2011

Early exposure to social deprivation and neglect linked to prematurely shortened telomeres in children

Studies in institutionalized Romanian children have found that the length of time spent in conditions of social deprivation and neglect correlates with lower IQ and behavioral problems. A new study, led by researchers at Children's Hospital Boston and Tulane University, shows that early adversity even affects children's chromosomes – prematurely shortening the chromosome tips, known as telomeres, and hastening how quickly their cells "age."

17 May 2011

HASCO Medical acquires Wheelchair Vans of America and Mobility Freedom

HASCO Medical, Inc., a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today its acquisition of Mobility Freedom Inc. and Wheelchair Vans of America.

17 May 2011

Daiichi Sankyo, Regency Therapeutics launch SPRIX Nasal Spray for severe pain

Regency Therapeutics, a newly established division of Luitpold Pharmaceuticals, Inc., and its co-promotion partner Daiichi Sankyo, Inc., announced today that they have launched SPRIX® (ketorolac tromethamine) Nasal Spray and that it is now commercially available.

17 May 2011

FDA grants 510(k) clearance to Asante's Pearl Insulin Pump

Asante Solutions, Inc., a medical device company focused on diabetes care, announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company's Pearl Insulin Pump. Last month, the Pearl also received the CE Mark, a European proof of conformity that certifies the product meets EU safety, health and environmental requirements.

17 May 2011

Cellular 'mechanic' keeps DNA damage in check in cells

CANCER RESEARCH UK scientists have discovered how a protein in immune cells plays an essential role in their development by repairing DNA damage - and if this protein is missing lymphomas can form.

17 May 2011

Researchers lay foundation for future lung cancer detection test

Scientists working with Professor Dr. Joachim L. Schultze have identified over 480 molecules whose concentration in the blood changes when a person develops lung cancer. These molecules are present in the blood cells either in increased or decreased quantities. "In lung cancer patients, typical patterns which can be detected with a measuring program thus emerge", explains Prof. Schultze.

17 May 2011

HII, CDISC launch new project to harmonize health research guidelines

A Project to harmonize health research guidelines was launched today by the Health Improvement Institute in partnership with the Clinical Data Interchange Standards Consortium.

17 May 2011

New avenue for treating breast cancer

Researchers at the CHUM Research Centre and the Peter MacCallum Cancer Centre in Australia have identified a new avenue for treating breast cancer.

17 May 2011

WellAWARE Systems earns RichTech Technology Innovation: Healthcare Award

WellAWARE Systems, the developer of breakthrough technology designed to enable proactive and preventive senior care, announced it was recognized with the Technology Innovation: Healthcare Award given by RichTech.

17 May 2011

Accelr8 presents initial ICU pilot study results at ATS International Conference

Accelr8 Technology Corporation announced that clinical investigators led by Ivor S. Douglas, MD/FRCP (UK) from Denver Health presented initial ICU pilot study results at the 2011 ATS International Conference.

17 May 2011

First Edition: May 17, 2011

Reporting for Kaiser Health News, in collaboration with The Washington Post, Guy Gugliotta writes: "Minnesota state Rep. Steve Gottwalt, a three-term Republican with 10 years experience in the health care industry, is no fan of last year's health care law -- or its requirement that states set up insurance exchanges. But as chairman of the Health and Human Services Reform Committee, he decided he needed to weigh in on the exchange.

17 May 2011

Medsphere achieves complete EHR certification for OpenVista solution

Medsphere Systems Corporation, the leading provider of open-source healthcare enterprise solutions, today announced complete electronic health record certification in inpatient settings for the company's OpenVista electronic health record.

17 May 2011

Fifty patients to receive complimentary cataract surgery from Kremer Eye Center

A team from Kremer Eye Center is traveling to Belize City, Belize to provide essential eye care June 18-25, 2011. Fifty patients will receive complimentary cataract surgery.

17 May 2011

Zimmer launches new Trabecular Metal augments for use in knee revision surgeries

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced the launch of a new, comprehensive range of Trabecular Metal Material augment shapes and cones for use in knee revision surgeries.

17 May 2011

LifeVantage fiscal third quarter net revenue increases 270% to $10.0 million

LifeVantage Corporation, the maker of science-based solutions to oxidative stress, today, reported financial results for the third quarter and first nine months of fiscal 2011 ended March 31, 2011.

17 May 2011

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.

17 May 2011

Connecture, MAXIMUS partner to deliver comprehensive government Health Insurance Exchange solution

MAXIMUS, Inc., a leading provider of government services worldwide, and Connecture, the leader in Web-based marketplaces and administration solutions for health insurance distribution, announced today that the two companies have entered into a strategic alliance.

17 May 2011

Pfizer seeks U.S. FDA, Japanese MHLW approval for crizotinib NDA to treat ALK-positive advanced NSCLC

Pfizer Inc. announced today that its New Drug Application for crizotinib, an oral first-in-class anaplastic lymphoma kinase inhibitor, has been accepted for filing and granted Priority Review status by the U.S. Food and Drug Administration and has been filed with the Japanese Ministry of Health, Labour and Welfare.

17 May 2011

Celgene, Foundation Medicine partner for clinical cancer genomic testing platforms

Foundation Medicine, Inc., a personalized cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine clinical care, today announced a strategic collaboration with Celgene Corporation.

17 May 2011

Medical News

Pernix first quarter net revenues increase 14% to $10.1 million

Early exposure to social deprivation and neglect linked to prematurely shortened telomeres in children

HASCO Medical acquires Wheelchair Vans of America and Mobility Freedom

Daiichi Sankyo, Regency Therapeutics launch SPRIX Nasal Spray for severe pain

FDA grants 510(k) clearance to Asante's Pearl Insulin Pump

Cellular 'mechanic' keeps DNA damage in check in cells

Researchers lay foundation for future lung cancer detection test

HII, CDISC launch new project to harmonize health research guidelines

New avenue for treating breast cancer

WellAWARE Systems earns RichTech Technology Innovation: Healthcare Award

Accelr8 presents initial ICU pilot study results at ATS International Conference

First Edition: May 17, 2011

Medsphere achieves complete EHR certification for OpenVista solution

Fifty patients to receive complimentary cataract surgery from Kremer Eye Center

Zimmer launches new Trabecular Metal augments for use in knee revision surgeries

LifeVantage fiscal third quarter net revenue increases 270% to $10.0 million

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Connecture, MAXIMUS partner to deliver comprehensive government Health Insurance Exchange solution

Pfizer seeks U.S. FDA, Japanese MHLW approval for crizotinib NDA to treat ALK-positive advanced NSCLC

Celgene, Foundation Medicine partner for clinical cancer genomic testing platforms

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News